Related Experiment Video
Updated: Jun 19, 2026

An Inertial Measurement Unit Based Method to Estimate Hip and Knee Joint Kinematics in Team Sport Athletes on the Field
Published on: May 26, 2020
Medication use by athletes during the Athens 2004 Paralympic Games
C Tsitsimpikou1, A Jamurtas, K Fitch
1Department of Physical Education and Sport Sciences, University of Thessaly, Trikala, Greece.
Elite Paralympic athletes commonly use medications and food supplements, with a rational approach observed. However, consumption trends require further study and athlete counseling is recommended.
Area of Science:
- Sports Science
- Doping Control
- Paralympic Athletics
Background:
- Understanding supplement and medication use in elite athletes is crucial for fair play and athlete health.
- Limited research exists on the specific patterns of use among elite Paralympic athletes.
Purpose of the Study:
- To investigate the prevalence and patterns of food supplement and pharmaceutical preparation use among elite Paralympic athletes.
- To compare consumption patterns with those of Olympic athletes.
Main Methods:
- A survey study conducted at the Athens 2004 Paralympic Games.
- Data collected via doping control records and therapeutic use exemption applications.
- Classification of supplements by active ingredient and medications by therapeutic action.
Main Results:
- 64.2% of athletes declared use of medications or supplements, with most using fewer than four.
- Food supplements were popular (42.1%); non-steroidal anti-inflammatory agents and analgesics were common.
- Inhaled beta2-agonist use (4.8%) was notably higher than in the Olympic Games.
Conclusions:
- Paralympic athletes demonstrate a rational approach to supplement and medication use, similar to Olympic athletes.
- Consumption trends remain unclear due to a lack of extensive research in this population.
- Counseling on nutritional needs and close monitoring by healthcare professionals are essential for athletes with disabilities.
Related Concept Videos
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Pharmaceutical Poisoning: Potential Scenarios
Drug Dosing: Geriatric Patients
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
